Bevacizumab, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Stage II or III Multiple Myeloma

NCT00410605 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

NIH

Sponsor class

Conditions

Multiple Myeloma in Relapse
Stage II Multiple Myeloma
Stage III Multiple Myeloma

Interventions

BIOLOGICAL: bevacizumab
DRUG: lenalidomide
DRUG: dexamethasone

Sponsor

National Cancer Institute (NCI)